financetom
Business
financetom
/
Business
/
Paylocity Holding Insider Sold Shares Worth $394,592, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paylocity Holding Insider Sold Shares Worth $394,592, According to a Recent SEC Filing
Mar 14, 2024 1:45 PM

04:17 PM EDT, 03/14/2024 (MT Newswires) -- Jeffrey T Diehl, Director, on March 12, 2024, sold 2,331 shares in Paylocity Holding ( PCTY ) for $394,592. Following the Form 4 filing with the SEC, Diehl has control over a total of 85,804 shares of the company, with 25,822 shares held directly and 59,982 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1591698/000159169824000079/xslF345X03/wk-form4_1710446788.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bio-Path Holdings Shares Were On The Rise: What's Going On?
Bio-Path Holdings Shares Were On The Rise: What's Going On?
Dec 19, 2024
Bio-Path Holdings, Inc ( BPTH ). shares are surging Thursday following the company's announcement of encouraging preclinical results for BP1001-A, a potential treatment for obesity and Type 2 diabetes. Here’s what you need to know. What To Know: The preclinical studies demonstrated that BP1001-A enhances insulin sensitivity by downregulating the growth factor receptor-bound protein 2. These findings suggest BP1001-A could...
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
Dec 19, 2024
On Thursday, Omeros Corporation ( OMER ) announced that an independent statistical group has completed the primary statistical analysis agreed with the FDA for narsoplimab. Omeros ( OMER ) is a first-in-class monoclonal antibody that inhibits the lectin pathway of complement in hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). TA-TMA is a complication in adult and pediatric hematopoietic stem cell...
--Liberty Media's Planned Acquisition of MotoGP Faces EU Scrutiny
--Liberty Media's Planned Acquisition of MotoGP Faces EU Scrutiny
Dec 19, 2024
12:29 PM EST, 12/19/2024 (MT Newswires) -- Price: 84.90, Change: +1.24, Percent Change: +1.49 ...
EU opens probe into Liberty Media's proposed Dorna Sports acquisition
EU opens probe into Liberty Media's proposed Dorna Sports acquisition
Dec 19, 2024
BRUSSELS, Dec 19 (Reuters) - The European Commission said on Thursday it had opened an in-depth investigation into the proposed 3.5 billion euro ($3.62 billion) acquisition of Dorna Sports by Liberty Media ( LLYVB ). Liberty Media ( LLYVB ) said in April that it would acquire about 86% of Dorna Sports, the parent company of FIM World Championship Grand...
Copyright 2023-2026 - www.financetom.com All Rights Reserved